来自前列腺瘤的细胞外囊泡以mTOR/RAB1A依赖的方式重塑转移前的骨环境
Tingting Lv1, Yawen Guo1, Yuehua Zhang1
1Department of Immuno-Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in immunology
|October 6, 2025
概括
这项研究揭示了mTOR/RAB1A信号如何控制前列腺癌 (PCa) 骨转移中的细胞外囊 (EV) 分泌. 抑制EV分泌提供了一种治疗策略,通过逆转免疫抑制来抵抗骨转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨转移是晚期前列腺癌 (PCa) 的一个主要挑战,与预后不佳有关.
- 目前针对哺乳动物的拉巴胺素 (mTOR) 抑制疗法由于途径的复杂性而显示出有限的疗效.
- 前列腺癌细胞在转移之前通过细胞外囊泡 (EVs) 重塑骨微环境.
研究的目的:
- 研究PCa中EV生物发生的调节机制.
- 确定EVs对骨前转移性 (PMN) 的影响.
- 开发针对骨转移的新型治疗策略.
主要方法:
- 西部涂抹 (WB) 检测mTOR和Ras相关蛋白质Rab-1A (RAB1A) 的表达.
- 功能性测试 (入侵,扩散) 和EV的特征 (WB,NTA,TEM).
- 对骨髓细胞子群和用EVs治疗的动物模型的分析.
主要成果:
- mTOR激活通过抑制其无处不在,促进EV分泌来稳定RAB1A.
- 来自瘤的EV诱导骨免疫抑制,B细胞功能障碍和髓状细胞扩张,形成PMN.
- 在RAB1A过度表达的PCa模型中抑制EV分泌改善了生存率和免疫细胞平衡.
结论:
- 阐明了调节EV分泌和PMN形成的mTOR/RAB1A机制.
- RAB1A是一种治疗点,用于抵消PCa中EV介导的免疫抑制.
- 外围B细胞动态可以作为早期转移检测的诊断生物标志物.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


